Session » Posters: Quality, Health Services, and Education Research II

Date: Friday, March 20, 2026

Time: 5:00PM-6:00PM

Meeting: 2026 Pediatric Rheumatology Symposium

5:00PM-6:00PM: Abstract Number: 122

Assessing the Relationship Between Multidimensional Area Level Indicators and Lupus Disease Activity in Children

5:00PM-6:00PM: Abstract Number: 119

Expansion of Mental Health Screening to Patients with Diverse Rheumatologic Diagnoses in an Outpatient Pediatric Rheumatology Clinic

5:00PM-6:00PM: Abstract Number: 124

Patient perspectives, barriers, and next steps in a health care transition clinic for pediatric to adult rheumatology

5:00PM-6:00PM: Abstract Number: 131

Reflections on the Creation of a Transition Clinic and the First 6-months of a Registry for Young Adults with Juvenile Idiopathic Arthritis: The Women’s College Hospital Experience

5:00PM-6:00PM: Abstract Number: 121

Representation of Skin of Color Among Pediatric Images in ACR Image Library

5:00PM-6:00PM: Abstract Number: 130

Resilience, Cumulative Social Disadvantage, and Disease Activity in Juvenile Idiopathic Arthritis (JIA)

5:00PM-6:00PM: Abstract Number: 129

Selection of Core Measures in Development of a Childhood Arthritis and Rheumatology Research Alliance based Pediatric Pain Registry for Management of Amplified Musculoskeletal Pain Syndrome

5:00PM-6:00PM: Abstract Number: 127

Setting the Stage for an Effective, Accessible, and Patient-Centered Nature-Based Intervention for Adolescents with Juvenile Idiopathic Arthritis (JIA)

5:00PM-6:00PM: Abstract Number: 123

The Details Matter: A Patient Centered Approach to Overcoming Barriers in a Pediatric to Adult Rheumatology Transition Clinic

5:00PM-6:00PM: Abstract Number: 128

Trends in Medicaid Enrollment Churn Among Children with Rheumatic Disease Diagnoses, 2018-2023

« View all sessions from this meeting

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].